Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Evaluation of acridinedione analogs as potential SARS-CoV-2 main protease inhibitors and their comparison with repurposed anti-viral drugs
Vijay Kumar Bhardwaj, Rahul Singh, Pralay Das, et al.
Computers in Biology and Medicine (2020) Vol. 128, pp. 104117-104117
Open Access | Times Cited: 100

Showing 1-25 of 100 citing articles:

An in-silico evaluation of different bioactive molecules of tea for their inhibition potency against non structural protein-15 of SARS-CoV-2
Jatin Sharma, Vijay Kumar Bhardwaj, Rahul Singh, et al.
Food Chemistry (2020) Vol. 346, pp. 128933-128933
Open Access | Times Cited: 177
Identification of potential plant bioactive as SARS-CoV-2 Spike protein and human ACE2 fusion inhibitors
Rahul Singh, Vijay Kumar Bhardwaj, Jatin Sharma, et al.
Computers in Biology and Medicine (2021) Vol. 136, pp. 104631-104631
Open Access | Times Cited: 90
Calendulaglycoside A showing potential activity against SARS-CoV-2 main protease: Molecular docking, molecular dynamics, and SAR studies
Ahmed A. Zaki, Ahmed Ashour, Sameh S. Elhady, et al.
Journal of Traditional and Complementary Medicine (2021) Vol. 12, Iss. 1, pp. 16-34
Open Access | Times Cited: 88
Recent Developments in Free Energy Calculations for Drug Discovery
Edward J. King, Erick Aitchison, Han Li, et al.
Frontiers in Molecular Biosciences (2021) Vol. 8
Open Access | Times Cited: 86
In-silico evaluation of bioactive compounds from tea as potential SARS-CoV-2 nonstructural protein 16 inhibitors
Rahul Singh, Vijay Kumar Bhardwaj, Jatin Sharma, et al.
Journal of Traditional and Complementary Medicine (2021) Vol. 12, Iss. 1, pp. 35-43
Open Access | Times Cited: 83
Potential of turmeric-derived compounds against RNA‐dependent RNA polymerase of SARS‐CoV‐2: An in-silico approach
Rahul Singh, Vijay Kumar Bhardwaj, Rituraj Purohit
Computers in Biology and Medicine (2021) Vol. 139, pp. 104965-104965
Open Access | Times Cited: 71
A computational approach for rational discovery of inhibitors for non-structural protein 1 of SARS-CoV-2
Rahul Singh, Vijay Kumar Bhardwaj, Pralay Das, et al.
Computers in Biology and Medicine (2021) Vol. 135, pp. 104555-104555
Open Access | Times Cited: 66
Identification of acridinedione scaffolds as potential inhibitor of DENV‐2 C protein: An in silico strategy to combat dengue
Sachin Kumar, Vijay Kumar Bhardwaj, Rahul Singh, et al.
Journal of Cellular Biochemistry (2022) Vol. 123, Iss. 5, pp. 935-946
Closed Access | Times Cited: 61
Ebsulfur and Ebselen as highly potent scaffolds for the development of potential SARS-CoV-2 antivirals
Le-Yun Sun, Cheng Chen, Jian-Peng Su, et al.
Bioorganic Chemistry (2021) Vol. 112, pp. 104889-104889
Open Access | Times Cited: 59
Bioactive Molecules of Tea as Potential Inhibitors for RNA-Dependent RNA Polymerase of SARS-CoV-2
Vijay Kumar Bhardwaj, Rahul Singh, Jatin Sharma, et al.
Frontiers in Medicine (2021) Vol. 8
Open Access | Times Cited: 55
Methodology-Centered Review of Molecular Modeling, Simulation, and Prediction of SARS-CoV-2
Kaifu Gao, Rui Wang, Jiahui Chen, et al.
Chemical Reviews (2022) Vol. 122, Iss. 13, pp. 11287-11368
Open Access | Times Cited: 54
Molecular Docking and Molecular Dynamics Simulations Discover Curcumin Analogue as a Plausible Dual Inhibitor for SARS-CoV-2
Shailima Rampogu, Gihwan Lee, Jun Sung Park, et al.
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 3, pp. 1771-1771
Open Access | Times Cited: 39
Identification of RdRp inhibitors against SARS-CoV-2 through E-pharmacophore-based virtual screening, molecular docking and MD simulations approaches
Hafiz Muzzammel Rehman, Muhammad Sajjad, Muhammad Akhtar Ali, et al.
International Journal of Biological Macromolecules (2023) Vol. 237, pp. 124169-124169
Open Access | Times Cited: 22
Targeting human arginyltransferase and post-translational protein arginylation: a pharmacophore-based multilayer screening and molecular dynamics approach to discover novel inhibitors with therapeutic promise
Rahul Naga, Sumon Poddar, Atanu Jana, et al.
SAR and QSAR in environmental research (2025), pp. 1-28
Closed Access
Characterization of the non-covalent interaction between the PF-07321332 inhibitor and the SARS-CoV-2 main protease
Marina Macchiagodena, Marco Pagliai, Piero Procacci
Journal of Molecular Graphics and Modelling (2021) Vol. 110, pp. 108042-108042
Open Access | Times Cited: 40
Benchmarking the ability of novel compounds to inhibit SARS-CoV-2 main protease using steered molecular dynamics simulations
Rahul Singh, Vijay Kumar Bhardwaj, Pralay Das, et al.
Computers in Biology and Medicine (2022) Vol. 146, pp. 105572-105572
Open Access | Times Cited: 34
Drug repurposing for SARS-CoV-2 main protease: Molecular docking and molecular dynamics investigations
Samia E. Omer, Tawasol M. Ibrahim, Omer A. Krar, et al.
Biochemistry and Biophysics Reports (2022) Vol. 29, pp. 101225-101225
Open Access | Times Cited: 30
Theaflavin 3-gallate inhibits the main protease (Mpro) of SARS-CoV-2 and reduces its count in vitro
Mahima Chauhan, Vijay Kumar Bhardwaj, Asheesh Kumar, et al.
Scientific Reports (2022) Vol. 12, Iss. 1
Open Access | Times Cited: 28
Single nucleotide polymorphisms located in TNFA, IL1RN, IL6R, and IL6 genes are associated with COVID‐19 risk and severity in an Iranian population
Mohsen Rokni, Mohammad Sarhadi, Milad Heidari Nia, et al.
Cell Biology International (2022) Vol. 46, Iss. 7, pp. 1109-1127
Open Access | Times Cited: 27
Molecular docking analysis reveals the functional inhibitory effect of Genistein and Quercetin on TMPRSS2: SARS-COV-2 cell entry facilitator spike protein
Reji Manjunathan, Vijayalakshmi Periyaswami, Kartik Mitra, et al.
BMC Bioinformatics (2022) Vol. 23, Iss. 1
Open Access | Times Cited: 26
Comparative docking studies of drugs and phytocompounds for emerging variants of SARS-CoV-2
Ananya Chugh, Ishita Sehgal, Nimisha Khurana, et al.
3 Biotech (2023) Vol. 13, Iss. 1
Open Access | Times Cited: 16
In Silico Investigation of Novel Compounds as Inhibitors of Acetylcholinesterase Enzyme for the Treatment of Alzheimer’s Diseases
Kassim F. Adebambo, Oghenekevwe Ojoh
International Journal of Alzheimer s Disease (2024) Vol. 2024, pp. 1-19
Open Access | Times Cited: 5
Virtual Screening of Phytochemicals by Targeting HR1 Domain of SARS-CoV-2 S Protein: Molecular Docking, Molecular Dynamics Simulations, and DFT Studies
Arshia Majeed, Waqar Hussain, Farkhanda Yasmin, et al.
BioMed Research International (2021) Vol. 2021, pp. 1-19
Open Access | Times Cited: 32
Design, synthesis, and molecular dynamics simulation studies of quinoline derivatives as protease inhibitors against SARS-CoV-2
Vishal Singh, Himani Chaurasia, Priyanka Kumari, et al.
Journal of Biomolecular Structure and Dynamics (2021) Vol. 40, Iss. 21, pp. 10519-10542
Open Access | Times Cited: 32
Design of SARS-CoV-2 Main Protease Inhibitors Using Artificial Intelligence and Molecular Dynamic Simulations
Lars Elend, Luise Jacobsen, Tim Cofala, et al.
Molecules (2022) Vol. 27, Iss. 13, pp. 4020-4020
Open Access | Times Cited: 21
Page 1 - Next Page

Scroll to top